Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases

<p>Abstract</p> <p>Colorectal small cell carcinoma (SmCC) is a rare tumor with an aggressive course. The aim of this study is to summarize our experience with this tumor and to highlight its immunohistochemical profile. Ten cases of colorectal SmCC were identified in our files and...

Full description

Bibliographic Details
Main Authors: Wong Shun, Ismiil Nadia, Khalifa Mahmoud A, El Demellawy Dina, Ghorab Zeina
Format: Article
Language:English
Published: BMC 2007-09-01
Series:Diagnostic Pathology
Online Access:http://www.diagnosticpathology.org/content/2/1/35
id doaj-7c03fefe73774a64961adcfb87a131c1
record_format Article
spelling doaj-7c03fefe73774a64961adcfb87a131c12020-11-25T01:56:13ZengBMCDiagnostic Pathology1746-15962007-09-01213510.1186/1746-1596-2-35Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 casesWong ShunIsmiil NadiaKhalifa Mahmoud AEl Demellawy DinaGhorab Zeina<p>Abstract</p> <p>Colorectal small cell carcinoma (SmCC) is a rare tumor with an aggressive course. The aim of this study is to summarize our experience with this tumor and to highlight its immunohistochemical profile. Ten cases of colorectal SmCC were identified in our files and a panel of immunostains was performed. Follow up was available for the average of 3 years, during which 7 patients died and 3 were alive with disease. All cases were positive for LMWK, CK 19 and pancytokeratin but were negative for TTF-1 and CA 125. EGFR was positive in 7 cases. TTF-1 negative staining may be valuable in differentiating it from its pulmonary counterpart. CDX2, mCEA, CD56, synaptophysin, NSE and chromogranin can help differentiate it from non-endocrine poorly differentiated adenocarcinoma. The expression of EGFR in a subset of patients has not been reported earlier and has to be evaluated in larger series to assess its role in the planning of targeted biologic therapy.</p> http://www.diagnosticpathology.org/content/2/1/35
collection DOAJ
language English
format Article
sources DOAJ
author Wong Shun
Ismiil Nadia
Khalifa Mahmoud A
El Demellawy Dina
Ghorab Zeina
spellingShingle Wong Shun
Ismiil Nadia
Khalifa Mahmoud A
El Demellawy Dina
Ghorab Zeina
Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases
Diagnostic Pathology
author_facet Wong Shun
Ismiil Nadia
Khalifa Mahmoud A
El Demellawy Dina
Ghorab Zeina
author_sort Wong Shun
title Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases
title_short Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases
title_full Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases
title_fullStr Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases
title_full_unstemmed Primary colorectal small cell carcinoma: A clinicopathological and immunohistochemical study of 10 cases
title_sort primary colorectal small cell carcinoma: a clinicopathological and immunohistochemical study of 10 cases
publisher BMC
series Diagnostic Pathology
issn 1746-1596
publishDate 2007-09-01
description <p>Abstract</p> <p>Colorectal small cell carcinoma (SmCC) is a rare tumor with an aggressive course. The aim of this study is to summarize our experience with this tumor and to highlight its immunohistochemical profile. Ten cases of colorectal SmCC were identified in our files and a panel of immunostains was performed. Follow up was available for the average of 3 years, during which 7 patients died and 3 were alive with disease. All cases were positive for LMWK, CK 19 and pancytokeratin but were negative for TTF-1 and CA 125. EGFR was positive in 7 cases. TTF-1 negative staining may be valuable in differentiating it from its pulmonary counterpart. CDX2, mCEA, CD56, synaptophysin, NSE and chromogranin can help differentiate it from non-endocrine poorly differentiated adenocarcinoma. The expression of EGFR in a subset of patients has not been reported earlier and has to be evaluated in larger series to assess its role in the planning of targeted biologic therapy.</p>
url http://www.diagnosticpathology.org/content/2/1/35
work_keys_str_mv AT wongshun primarycolorectalsmallcellcarcinomaaclinicopathologicalandimmunohistochemicalstudyof10cases
AT ismiilnadia primarycolorectalsmallcellcarcinomaaclinicopathologicalandimmunohistochemicalstudyof10cases
AT khalifamahmouda primarycolorectalsmallcellcarcinomaaclinicopathologicalandimmunohistochemicalstudyof10cases
AT eldemellawydina primarycolorectalsmallcellcarcinomaaclinicopathologicalandimmunohistochemicalstudyof10cases
AT ghorabzeina primarycolorectalsmallcellcarcinomaaclinicopathologicalandimmunohistochemicalstudyof10cases
_version_ 1724980806268485632